Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Change in Acquisitions & Divestments: 2009-2024

Historic Change in Acquisitions & Divestments for Myriad Genetics (MYGN) over the last 15 years, with Sep 2024 value amounting to $5.0 million.

  • Myriad Genetics' Change in Acquisitions & Divestments fell 66.67% to $5.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $10.5 million, marking a year-over-year decrease of 92.72%. This contributed to the annual value of $9.0 million for FY2024, which is 91.44% down from last year.
  • As of Q3 2024, Myriad Genetics' Change in Acquisitions & Divestments stood at $5.0 million, which was up 100.00% from $2.5 million recorded in Q2 2024.
  • In the past 5 years, Myriad Genetics' Change in Acquisitions & Divestments ranged from a high of $58.1 million in Q1 2023 and a low of $1.5 million during Q4 2023.
  • For the 3-year period, Myriad Genetics' Change in Acquisitions & Divestments averaged around $22.0 million, with its median value being $17.1 million (2022).
  • In the last 5 years, Myriad Genetics' Change in Acquisitions & Divestments soared by 318.90% in 2020 and then slumped by 97.42% in 2024.
  • Myriad Genetics' Change in Acquisitions & Divestments (Quarterly) stood at $35.9 million in 2020, then plummeted by 32.31% to $24.3 million in 2021, then skyrocketed by 67.08% to $40.6 million in 2022, then tumbled by 96.31% to $1.5 million in 2023, then plummeted by 66.67% to $5.0 million in 2024.
  • Its Change in Acquisitions & Divestments was $5.0 million in Q3 2024, compared to $2.5 million in Q2 2024 and $1.5 million in Q1 2024.